Acumen Pharmaceuticals, Inc. (ABOS) Executive Compensation
Acumen Pharmaceuticals, Inc. (ABOS) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ABOS
CIK: 1576885
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerStephen Matsick
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-09-16 | 2026-09-16 | 8-K | 0001628280-26-062137 | View SEC Doc Filr Page |
| S-8 | 2026-08-12 | — | S-8 | 0001628280-26-056240 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001628280-26-056199 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001628280-26-055940 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-15 | FORM 4 | 0001628280-26-043987 | View SEC Doc Filr Page |
| 144 | 2026-06-17 | — | 144 Filing | 0001950047-26-006245 | View SEC Doc Filr Page |
| 144 | 2026-06-16 | — | 144 Filing | 0001950047-26-006235 | View SEC Doc Filr Page |
| 8-K | 2026-06-16 | 2026-06-12 | 8-K | 0001628280-26-043416 | View SEC Doc Filr Page |
| 144 | 2026-06-15 | — | 144 Filing | 0001950047-26-006161 | View SEC Doc Filr Page |
| 4 | 2026-06-10 | 2026-06-09 | FORM 4 | 0001628280-26-042280 | View SEC Doc Filr Page |
| 144 | 2026-06-09 | — | 144 Filing | 0001950047-26-005810 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | 4 Filing | 0001231919-26-000604 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041281 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041276 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041273 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041272 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041270 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041268 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-03 | FORM 4 | 0001628280-26-041263 | View SEC Doc Filr Page |
| 8-K | 2026-06-03 | 2026-06-03 | 8-K | 0001628280-26-040447 | View SEC Doc Filr Page |
| 10-Q | 2026-05-12 | 2026-03-31 | 10-Q | 0001628280-26-034204 | View SEC Doc Filr Page |
| 8-K | 2026-05-12 | 2026-05-12 | 8-K | 0001628280-26-033868 | View SEC Doc Filr Page |
| ARS | 2026-04-23 | 2025-12-31 | ARS | 0001628280-26-026874 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-23 | — | DEFA14A | 0001628280-26-026871 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-23 | 2025-12-31 | DEF 14A | 0001628280-26-026870 | View SEC Doc Filr Page |